At this year's American Society of Clinical Oncology’s Annual Meeting, AstraZeneca presented late-breaking data from the DESTINY-Breast09 Phase III trial evaluating first-line treatment in patients ...

Asco has shared plans for his new album 'Perfect Timing'. The UK rapper is known as one of the best in his lane, with Asco's expert pen game inspiring his ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Context Therapeutics Inc. (NASDAQ: CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...

Mersana Therapeutics Inc. (NASDAQ: MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana Therapeutics presented additional positive interim Phase 1 clinical data for ...

These data support the use of sacituzumab plus pembrolizumab as a potential new standard of care,” said Sara Tolaney, MD.

A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...

Fotivda preserved quality-of-life scores in kidney cancer, with better outcomes in second-line use and no added benefit from combining with Opdivo.

The Food Patrol is focusing on one bakery with many issues. Police and lawyers are getting involved because maggots were ...

In this video, Sham Mailankody, MBBS, discusses results from a first-in-human study of JNJ-5322, a next-generation trispecific antibody for treatment of patients with relapsed or refractory multiple ...

Bonilla, MD, MSEd, discusses the significant advancements and ongoing efforts in integrating artificial intelligence into oncology.

To our knowledge, this is the first study that demonstrates a clinical advantage of proton therapy for NGGCT,” said David Y. Mak, MD.